Subsequently, we analyzed whether miR-625-3p expression in CD8+ T cells might predict the acute GvHD risk in patients with acute GvHD grade II-IV by comparing the last samples collected before onset of acute GvHD with samples collected during acute GvHD. This evidence concerns the gene CD8A and graft versus host disease.